Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.
about
Oral complications in hematopoietic stem cell recipients: the role of inflammationCurrent classification of the oral streptococci.Streptococcus mitis strains causing severe clinical disease in cancer patients.Circulating tumor necrosis factor alpha (TNF), soluble TNF receptors, and interleukin-6 in human subacute bacterial endocarditis.A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.The prophylaxis of bacterial infections in neutropenic patients.Evaluation of empiric vancomycin therapy in children with fever and neutropenia.Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantationValidation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group.Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview.Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.PCR-Based methods for genotyping viridans group streptococci.In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancer2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer.Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases.Mitral bioprosthetic valve endocarditis caused by an unusual microorganism, Gemella morbillorum, in an intravenous drug user.Practice guidelines for the diagnosis and management of skin and soft-tissue infections.Antibiotic prophylaxis in patients receiving hematopoietic stem cell transplant.Therapeutic strategies for chemotherapy-induced neutropenia in patients with solid tumors.Mucosal tissue injury in cancer therapy. More than muscositis and mouthwash.Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniaeEmergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxisIn vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants.Major outbreak of toxic shock-like syndrome caused by Streptococcus mitis.Streptococcus mitis cell walls and lipopolysaccharide induce lethality in D-galactosamine-sensitized mice by a tumor necrosis factor-dependent pathway.Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis.Perspectives for the management of febrile neutropenic patients with cancer in the 21st century.Infections in patients with febrile neutropenia: epidemiology, microbiology, and risk stratification.Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.Comparison of phenotypic characteristics, DNA-DNA hybridization results, and results with a commercial rapid biochemical and enzymatic reaction system for identification of viridans group streptococciDefining antibody targets in Streptococcus oralis infection.Cancer therapeutics: an update on its effects on oral health.Empiric therapy for febrile neutropenia: what are the choices?Infections with viridans group streptococci in children with cancer.Antibiotic prophylaxis for patients with acute leukemia.Febrile neutropenia.Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia.Management of gram-positive bacterial infections in patients with cancer.
P2860
Q27027650-BEE7ED6E-4CA0-4990-B575-BCBCDC17285BQ33545285-94FE8688-BF57-42BE-8A2B-F5943262A578Q33577127-0C1C1DA4-1F83-44EC-89D0-B737620521E5Q33618298-A81A1B35-264E-4CBA-A93E-380360EF385FQ33750614-68CC5EA5-0D72-4EFA-8002-943B3EE69645Q33769354-7DC96152-AD2A-40E6-84F9-9738075DECEFQ33771365-6E251B2D-3DF3-4558-A020-2CB138A27419Q33781213-B45878CF-076B-4785-8F81-68C827D27B6CQ33862023-C863E687-CD49-4100-AAA3-5E913D02C381Q33952985-35E83432-F306-4205-AD8E-6168D4BF1CE1Q33960926-676EB521-A58C-4762-8305-F3E173B7AD43Q33962369-E8B8229A-C672-4D25-80AD-C105D23C0200Q33981500-DB97C967-5398-41AD-946B-4C7504B57C54Q34114674-D3CE144E-A706-4268-8EBB-438098824239Q34315497-53D91E30-1BEA-4FBF-8E28-66D077B7275EQ34357176-5D5922BC-B071-4282-B243-7B0873006D03Q34460523-A3FED2A5-A1CB-4FE8-B3C1-E3D937CA96ABQ34580312-C5FD1BD1-5E34-4C8A-BE49-EB17A4B9D356Q34670717-3C3444A8-1CCD-4FC6-8FFC-C152B501AD69Q34722667-87C0FAAE-62AA-43EB-B78E-A4E1CCED96A4Q35102420-56227C93-C184-434F-A159-6C87D6881DEAQ35122694-3F8C0496-3572-4D6C-86B9-197DFC226E67Q35126797-3C281B32-194D-45CE-A091-F11DC848EC0DQ35136336-5D824A22-9EBB-42BA-90CD-E86725845F80Q35155639-569E4E7C-89A8-4AD7-8DF9-1774F5199161Q35492787-3214B6D6-6322-47BD-AFE2-DDDE6F2E6683Q35597437-11DED22F-6B35-45BD-98E5-58E613A772C4Q36017961-ABD295DE-089C-4C0E-9F88-66ED11BCDCE4Q36071289-06BF97B3-20CB-4F26-9C70-D23E3C60AA47Q36096410-B4B9EDB0-327F-454B-AAB6-E7FA9C6B9700Q36521851-A61E83FD-D569-461C-91D8-C9CFCDCF7AF3Q36797178-C664F527-9146-4A91-BC3A-E8A7DC294DBAQ36809165-89F81115-C071-4641-B57E-FFE461925B0EQ36839750-2F2432E4-9A2E-4CD1-B9BC-6D1EB45A341CQ36858122-538BAA6F-A977-4C3C-BE51-8DF3D8243AC1Q37071680-A7929F63-7513-4546-90AD-DBF06E192176Q37287945-3149F939-0C85-45AA-BA37-0D48A4B2295BQ37598714-6FF09100-8714-483D-9176-9FBE4EA4EF12Q37738468-027CE386-5EC3-4009-A92D-724D6DDB5B53Q37899198-A7C1BFA8-56FA-4A08-9248-01B48A7BDF75
P2860
Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Septicemia and shock syndrome ...... study of predisposing factors.
@en
type
label
Septicemia and shock syndrome ...... study of predisposing factors.
@en
prefLabel
Septicemia and shock syndrome ...... study of predisposing factors.
@en
P2093
P356
P1476
Septicemia and shock syndrome ...... study of predisposing factors.
@en
P2093
P304
P356
10.1093/CLINIDS/14.6.1201
P407
P577
1992-06-01T00:00:00Z